ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0601

Occupational Inhaled Agents Constitute Major Risk Factors for Rheumatoid Arthritis, Particularly in the Context of Genetic Predisposition and Smoking

Bowen Tang1, Qianwen Liu2, Anna Ilar3, Pernilla Wiebert2, Sara Hägg1, Leonid Padyukov2, Lars Klareskog2, Lars Alfredsson2 and Xia Jiang2, 1Karolinska Institutet, Solna, Sweden, 2Karolinska Institutet, Stockholm, Sweden, 3The National Board of Health and Welfare, Stockholm, Sweden

Meeting: ACR Convergence 2022

Keywords: Anti-citrullinated Protein Autoantibodies (ACPAs), Environmental factors, genetics, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: RA – Etiology and Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: The lung is recognized as a primary site in the induction of rheumatoid arthritis (RA). Our study aims to assess the effect of common occupational inhalable exposures on RA development and their interactions with smoking and RA-risk genes.

Methods: From 1996 to 2017, 4,033 incident RA cases and 6,485 controls matched on age, sex, and residential area were recruited from central and southern Sweden, all answering a self-administered questionnaire. For each participant, occupational history was retrieved, which together with information from a Swedish national job-exposure matrix allowed us to estimate the cumulative exposure to 32 different inhalable agents, taking prevalence and concentration into account. Approximately 3,400 cases and 2,800 controls had concomitant genetic data (genome-wide genotypes and human leucocyte antigen class II shared epitope (HLA-SE) genotypes). Two subtypes of RA were assessed based on the status of anti-citrullinated protein / peptide antibodies (ACPA), consisting of 2,642 ACPA-positive cases and 1,391 ACPA-negative cases.

Results: An increased risk of developing ACPA-positive RA was found for individuals ever exposed to any occupational inhalable agents (OR=1.25, 95%CI=1.12-1.38). The risk increased in a dose-response manner according to number of agents (Ptrend< 0.001) and duration of exposure (Ptrend< 0.001). When jointly considering occupational inhalable agents, smoking, and genetic risk score (GRS), a markedly elevated risk of developing ACPA-positive RA was observed among participants who were exposed to all three factors compared with those not exposed to any (OR=18.22, 95%CI=11.77-28.19). A significant interaction on the additive scale was found between occupational inhalable agents (ever exposed to any) and smoking for overall RA (attributable proportion due to interaction (AP)=0.19, 95%CI=0.08-0.31). A gene-environment interaction (with GRS or HLA-SE) was observed for a number of specific inhalable agents restricting to ACPA-positive RA, including quartz (GRS: AP=0.36, 95%CI=0.08-0.63; HLA-SE: AP=0.42, 95%CI=0.15-0.68), asbestos (GRS: AP=0.44, 95%CI=0.13-0.74; HLA-SE: AP=0.41, 95%CI=0.08-0.75), carbon monoxide (GRS: AP=0.23, 95%CI=0.01-0.45; HLA-SE: AP=0.29, 95%CI=0.07-0.51), fungicides (GRS: AP=0.56, 95%CI=0.19-0.93) and gasoline engine exhaust (GRS: AP=0.52, 95%CI=0.23-0.80; HLA-SE: AP=0.48, 95%CI=0.16-0.79). On the contrary, no indication of interaction was found in ACPA-negative subtype.

Conclusion: Occupational inhalable agents could act as important environmental triggers in RA development and interact with smoking and RA-risk genes leading to an excessive disease risk. These effects are specific to ACPA-positive RA. Preventive strategies aimed at reducing occupational hazards and smoking are warranted for reduction of the burden of RA, especially for those who are genetically vulnerable.

Supporting image 1

Primary associations of individual occupational inhalable agents with RA.

Supporting image 2

Exposure-response relationship between occupational inhalable agents and RA. a) Participants were classified into exposed to 1, 2, 3, 4, or >=5 particles out of the 16 independent particles and compared to non-exposed group (not exposed to any of the 47 particles). b) Participants were classified into five subsets with exposure durations of 0_3.3, 3.3-8.0, 8.0_1.5, 1.5_24.0, 24.0-51.0 years (to any particles) and compared to non-exposed group (not exposed to any of the 47 particles). Results are shown for overall RA, as well as ACPA-positive and ACPA-negative subtypes. Estimates adjusted for age, sex, residential area, smoking, alcohol drinking, education, and BMI.

Supporting image 3

The combined effect of inhalable agents, smoking, and high genetic risk score with risk of RA. The results for five common occupational inhalable agents were shown in the figure, and the estimates were adjusted for age, sex, residential area, BMI, levels of education, alcohol drinking, and PCs 1_10.


Disclosures: B. Tang, None; Q. Liu, None; A. Ilar, None; P. Wiebert, None; S. Hägg, None; L. Padyukov, None; L. Klareskog, None; L. Alfredsson, None; X. Jiang, None.

To cite this abstract in AMA style:

Tang B, Liu Q, Ilar A, Wiebert P, Hägg S, Padyukov L, Klareskog L, Alfredsson L, Jiang X. Occupational Inhaled Agents Constitute Major Risk Factors for Rheumatoid Arthritis, Particularly in the Context of Genetic Predisposition and Smoking [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/occupational-inhaled-agents-constitute-major-risk-factors-for-rheumatoid-arthritis-particularly-in-the-context-of-genetic-predisposition-and-smoking/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/occupational-inhaled-agents-constitute-major-risk-factors-for-rheumatoid-arthritis-particularly-in-the-context-of-genetic-predisposition-and-smoking/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology